Concepedia

Manu Prasad

MP

17

Publications

540

Citations

14

H-Index

2009

Active since

Affiliations

Ben-Gurion University of the Negev(Current)

Soroka Medical Center

German Cancer Research Center

Heidelberg University

Memorial Sloan Kettering Cancer Center

Manu Prasad is an author at Ben-Gurion University of the Negev specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

2009–2023

17

Publications

17

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan et al. · Journal for ImmunoTherapy of Cancer · 2022 · 66 citations · Full text

Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy

Mai Badarni, Manu Prasad, Noa Balaban et al. · JCI Insight · 2019 · 65 citations · Full text

, , +23

TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer

Ksenia M. Yegodayev, Ofra Novoplansky, Artemiy Golden et al. · Cancers · 2020 · 54 citations · Full text

IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer

Jonathan Zorea, Manu Prasad, Limor Cohen et al. · Cell Death and Disease · 2018 · 47 citations · Full text

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Joris L. Vos, Bharat Burman, Swati Jain et al. · Nature Medicine · 2023 · 47 citations · Full text

, , +7

Rows per page

1–5 of 17